Literature DB >> 26343139

Oleanolic Acid A-lactams Inhibit the Growth of HeLa, KB, MCF-7 and Hep-G2 Cancer Cell Lines at Micromolar Concentrations.

Barbara Bednarczyk-Cwynar1, Piotr Ruszkowski, Teresa Bobkiewicz-Kozlowska, Lucjusz Zaprutko.   

Abstract

Oleanolic acid ketones, oximes, lactams and nitriles were obtained. Complete spectral characterizations (IR, (1)H NMR, (13)C NMR, DEPT and MS) of the synthesized compounds are presented. The derivatives had oxo, hydroxyimino, lactam or nitrile functions at the C-3 position, an esterified or unmodified carboxyl group at the C- 17 location and, in some cases, an additional oxo function at the C-11 position. The new compounds were tested for cytotoxic activity on the HeLa, KB, MCF-7 and Hep-G2 cancer cell lines with the application of MTT [3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] test. Among the tested compounds, some oximes and all lactams proved to be the most active cytotoxic agents. These triterpenes significantly inhibited the growth of the HeLa, KB, MCF-7 and Hep-G2 cancer cell lines at micromolar concentrations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26343139     DOI: 10.2174/1871520615666150907095756

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  2 in total

Review 1.  Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy.

Authors:  Lovro Žiberna; Dunja Šamec; Andrei Mocan; Seyed Fazel Nabavi; Anupam Bishayee; Ammad Ahmad Farooqi; Antoni Sureda; Seyed Mohammad Nabavi
Journal:  Int J Mol Sci       Date:  2017-03-16       Impact factor: 5.923

2.  The Effect of Novel Oleanolic Acid Oximes Conjugated with Indomethacin on the Nrf2-ARE And NF-κB Signaling Pathways in Normal Hepatocytes and Human Hepatocellular Cancer Cells.

Authors:  Maria Narożna; Violetta Krajka-Kuźniak; Barbara Bednarczyk-Cwynar; Robert Kleszcz; Jacek Kujawski; Wanda Baer-Dubowska
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.